VALGENT: a protocol for clinical validation of human papillomavirus assays

Arbyn, Marc, Depuydt, Christophe, Benoy, Ina, Bogers, Johannes, Cuschieri, Kate, Schmitt, Markus, Pawlita, Michael, Geraets, Daan +6 more·2016·Journal of Clinical Virology
DOI 10.1016/j.jcv.2015.09.014

Cited by (157)

Items 101–157 of 157

  1. The new screening program to prevent cervical cancer using HPV DNA: getting the balance right in maintaining quality
    Suzanne Marie Garland, Wayne J. Dimech, Peter Collignon, Louise Cooley, Graeme R. Nimmo, David W Smith, Rob Baird, William D. Rawlinson, Anna‐Maria Costa, Geoff Stuart Higgins · 2018 · The Journal of Pathology Clinical Research
  2. Quality Assurance in Cervical Cancer Screening: Evaluation of Sample Adequacy in HPV DNA Testing
    Morena d’Avenia, Filippo Dell’Anno, Marianna Martinelli, L. Santomauro, Ruth Chinyere Njoku, Laila Sara Arroyo Mühr, Michela Iacobellis, Clementina Elvezia Cocuzza · 2025 · Journal of Medical Virology
  3. A comparison of the MeltPro® HPV Test with the Cobas® HPV Test for detecting and genotyping 14 high-risk human papillomavirus types
    Zhiteng Tang, Ye Xu, Najie Song, Dongqing Zou, Yiqun Liao, Qingge Li, Chao Pan · 2017 · Archives of Virology
  4. Accuracy of Liferiver HarmoniaHPV and VenusHPV Assays on Urine and Vaginal Self‐Samples
    Ardashel Latsuzbaia, Severien Van Keer, Davy Vanden Broeck, Steven Weyers, Gilbert G.G. Donders, Philippe De Sutter, Wiebren A.A. Tjalma, Jean Doyen, Alex Vorsters, Marc Arbyn · 2025 · Journal of Medical Virology
  5. Extended HPV genotyping and dual stain for the triage of primary HPV screen‐positive cases: Practical guidance for the cytopathology laboratory
    Robert A. Goulart, Ritu Nayar, Thomas S. Lorey, Nancy E. Joste, Mark H. Stoler · 2025 · Cancer Cytopathology
  6. Molecular Screening for Cervical Cancer
    Toni Ricardo Martins, José Eduardo Levi · 2025 · Genes
  7. Clinical validation of the Roche cobas HPV test on the Roche cobas 5800 system for the purpose of cervical screening
    Nikita Mehta, Marco Ho Ting Keung, Eunice Pineda, Elliott Lynn, Dagnachew Muluye Fetene, Alvin Yuan Ming Lee, Nicolas Hougardy, Amélie Heinrichs, Hiu Tat Chan, Marc Arbyn et al. · 2024 · Microbiology Spectrum
  8. The Sansure® Human Papillomavirus DNA Diagnostic Kit offers excellent reproducibility performance for the detection of high‐risk HPV
    Jean‐Luc Prétet, Alice Baraquin, Pui Yan Jenny Chung, Line Puget, Sharonjit Kaur Dhillon, Yuliya Tkachenka, Killian Jacquot, Quentin Lepiller, Davy Vanden Broeck, Marc Arbyn · 2024 · Journal of Medical Virology
  9. Evaluation of HarmoniaHPV test for detection of clinically significant Human Papillomavirus infection using the VALGENT framework
    Ramya Bhatia, Elia Alcañiz Boada, Jesper Hansen Bonde, Wim G.V. Quint, Irene Kraus Christiansen, Lan Xu, Ditte Møller Ejegod, Sharon Moncur, Kate S. Cuschieri, Marc Arbyn · 2021 · Journal of Virological Methods
  10. Genotype-specific high-risk human papillomavirus infections and risk factors for cervical dysplasia in women with human immunodeficiency virus in Germany: results from a single-center cross-sectional study
    Alexandra Wagner, Anna Sophie Skof, Jalid Sehouli, Rolf Richter, Wolfgang Henrich, Katharina Weizsäcker, Jan-Peter Siedentopf, Radoslav Chekerov, Andreas Martin Kaufmann, Irena Rohr · 2022 · International Journal of Gynecological Cancer
  11. Development of a large biorepository of cervical specimens for the Improving Risk Informed HPV Screening study (IRIS)
    Tina R. Raine‐Bennett, Julia C. Gage, Nancy E. Poitras, Malini Chandra, Nicole E. Varnado, Brian Befano, MARK H. SCHIFFMAN, Thomas S. Lorey, Nicolas Wentzensen · 2021 · Journal of Clinical Virology
  12. Concordance between the BD Onclarity and Roche cobas assays for detection of HPV DNA in a Chinese population
    Yakun Wang, Tingyuan Li, Jian Yin, Yin Liu, Zhifang Li, Yujing Liu, Tingting Chen, Simiao Chen, Yu Dai, Jianfeng Cui et al. · 2022 · Journal of Medical Virology
  13. Evaluation of the clinical performance of OncoPredict HPV® SCR assay within the VALGENT‐2 framework
    Sharonjit Kaur Dhillon, Clementina Elvezia Cocuzza, Pui Yan Jenny Chung, Marianna Martinelli, Chiara Giubbi, Ruth Chinyere Njoku, Ramya Bhatia, Kate S. Cuschieri, Marc Arbyn · 2022 · Journal of Medical Virology
  14. Clinical Utility of Reflex Testing with Cancer Biomarkers to Improve Diagnostic Accuracy of Primary Human Papillomavirus Screening
    Lauren G. Johnson, Rakiya Saidu, Cecilia Svanholm-Barrie, Rosalind Boa, Jennifer Moodley, Ana Tergas, David H. Persing, Scott Campbell, Wei-Yann Tsai, Thomas C. Wright et al. · 2022 · Cancer Epidemiology Biomarkers & Prevention
  15. Intra‐ and interlaboratory reproducibility evaluation toward international validation status of the AmpFire assay
    Pui Yan Jenny Chung, Sharonjit Kaur Dhillon, Alice Baraquin, Yuliya Tkachenka, Killian Jacquot, Jean‐Luc Prétet, Davy Vanden Broeck, Marc Arbyn · 2024 · Journal of Medical Virology
  16. Papilloplex HR-HPV test has non-inferior clinical performance for detection of human papillomavirus infection: assessment using the VALGENT framework
    Ramya Bhatia, Elia Alcañiz Boada, Jesper Hansen Bonde, Wim G.V. Quint, Lan Xu, Ditte Møller Ejegod, Kate S. Cuschieri, Marc Arbyn · 2021 · Journal of Clinical Pathology
  17. The Key Role of Mathematical Modeling and Health Economics in the Public Health Transitions in Cervical Cancer Prevention
    Karen Canfell, Johannes Hans Berkhof · 2019 · Elsevier eBooks
  18. VALCOR: a protocol for the validation of SARS-corona virus-2 assays
    Marc Arbyn, Sharonjit Kaur Dhillon, Marianna Martinelli, Cindy Simoens, Lize Cuypers, Jannes Bode, Marc A. Van Ranst, Philippe Corbisier, Jesper Hansen Bonde, Clementina Elvezia Cocuzza · 2022 · Archives of Public Health
  19. Detection of high-risk HPV in FFPE specimens of various tumours using the BD Onclarity™ HPV Assay
    Robert van der Geize, Natalie Methorst, Maarten Niemantsverdriet · 2022 · Tumour Virus Research
  20. Assessment of high-risk human papillomavirus infections and associated cervical dysplasia in HIV-positive pregnant women in Germany: a prospective cross-sectional two-centre study
    Charlotte K. Metz, Anna Sophie Skof, Jalid Sehouli, Jan-Peter Siedentopf, Pimrapat Gebert, Fabian Weiß, Irene Alba Alejandre, Michaela Heinrich-Rohr, Katharina Weizsaecker, Wolfgang Henrich et al. · 2022 · Archives of Gynecology and Obstetrics
  21. Clinical implementation of a cervical cancer screening program via co-testing at a university hospital
    Valeria Cecilia Denninghoff, Felicitas von Petery, Cristóbal Fresno, Mercedes Galarza, Florencia Torres, Alejandra Avagnina, Vanina S. Fishkel, Hugo B. Krupitzki, Angel Fiorillo, F Barreda y Monge · 2022 · PLoS ONE
  22. Clinical Performance of the Full Genotyping Agena MassARRAY HPV Assay Using SurePath Screening Samples within the VALGENT4 Framework
    Helle Pedersen, Ditte Møller Ejegod, Wim G.V. Quint, Lan Xu, Marc Arbyn, Jesper Hansen Bonde · 2022 · Journal of Molecular Diagnostics
  23. Histologıcal results of HPV genotyping from a colposcopy center
    Sevgi Koç, Dilek Yüksel, Tuğba Kınay, Derya BURKANKULU, Fulya Kayıkçıoğlu · 2022 · Archives of Gynecology and Obstetrics
  24. Validation of the clinical performance and reproducibility of the NeuMoDx HPV assay self-sample workflow
    Daniëlle A.M. Heideman, Johannes Hans Berkhof, Lisanne Verhoef, C. Ouwerkerk, P.W Smit, Anja Oštrbenk, Jana Mlakar, Mario Poljak, Renske D.M. Steenbergen, Maaike C.G. Bleeker · 2024 · Journal of Clinical Virology
  25. Prevención y detección precoz del cáncer cervicouterino
    Oscar Puga S, Francisco Belmar, Emiliano Pertossi · 2024 · Revista Médica Clínica Las Condes
  26. Clinical performance of DNA and RNA based HPV tests for test of cure (TOC) post treatment for cervical intraepithelial neoplasia (CIN) - a retrospective study.
    Ramya Bhatia, Catriona Graham, Hana Elasifer, Priyanka Asodaria, Sharon Moncur, Allan Wilson, Timothy J. Palmer, Kate S. Cuschieri · 2022 · Journal of Clinical Virology
  27. Clinical and analytical performance of the CLART HPV 4S assay with SurePath screening samples from the Danish cervical cancer screening program using the VALGENT framework
    Ditte Møller Ejegod, Helle Pedersen, Wim G.V. Quint, Lan Xu, Marc Arbyn, Jesper Hansen Bonde · 2021 · Journal of Virological Methods
  28. Cervical cytology and HPV in cervical cancer screening
    Pooja Bakshi, Poojan Agarwal, Gunjan Mangla · 2023 · Current Medicine Research and Practice
  29. Nationwide implementation and evaluation of an external quality assessment program for HPV screening in Peru
    Pamela Rios, Luis Solís, Susan Espetia, Carina Eklund, Laila Sara Arroyo Mühr, Joakim Dillner, Andrea Matos, Maribel Acuña, George Obregón · 2025 · International Journal of Infectious Diseases
  30. Large‐Scale Study Comparing Analytical and Diagnostic Quality of Three HPV Self‐Sampling Devices for At‐Home Cervical Cancer Screening
    Alexander Arum, Emilie Korsgaard Andreasen, Helle Pedersen, Trine Dahl Nielsen, Peter Frandsen, Birgitte Tønnes Pedersen, Estrid Vilma Solyom Høgdall, Jesper Hansen Bonde · 2025 · Apmis
  31. Primary Human Papillomavirus Screening Versus Cytology for Detection of Cervical Intraepithelial Neoplasia Grade 2 or Higher in Poland: a Parallel-Group, Randomized Controlled Trial
    Andrzej Nowakowski, Anna Macios, Patrycja Glińska, Aneta Chmielewska, Beata Janik, Ilona Jędrzejewska, Alicja Klimiuk, Ewa Chmielik, Piotr Bobkiewicz, Ewa Kapuśniak et al. · 2026 · The Lancet Regional Health - Europe
  32. Assessment of the clinical and analytical performance of three Seegene Allplex SARS-CoV-2 assays within the VALCOR framework
    Pui Yan Jenny Chung, Sharonjit Kaur Dhillon, Cindy Simoens, Lize Cuypers, Lies Laenen, Jesper Hansen Bonde, Philippe Corbisier, Gerhard Buttinger, Clementina Elvezia Cocuzza, Steven Van Gucht et al. · 2024 · Microbiology Spectrum
  33. Can HPV Selfy be considered as a clinically validated HPV test for use in cervical cancer screening?
    Marc Arbyn, Jesper Hansen Bonde, Kate S. Cuschieri, Mario Poljak · 2022 · Journal of Translational Medicine
  34. Re: ‘2020 list of human papillomavirus assays suitable for primary cervical cancer screening’ by Arbyn et al.
    Giuseppe Giuffrè, Michela Iacobellis · 2023 · Clinical Microbiology and Infection
  35. Can REALQUALITY RQ-HPV screen be considered as a clinically validated HPV test for use in cervical cancer screening?
    Marc Arbyn, Kate S. Cuschieri, Mario Poljak, Jesper Hansen Bonde · 2023 · Clinical Microbiology and Infection
  36. Integrating a “see-and-treat” approach with opportunistic human papilloma virus deoxyribonucleic acid (HPV DNA) based cervical cancer screening in India: a retrospective cross-sectional study
    Rao, Sripriya, Chhabra, Mayank, Kudkuli, Jagadish, Toraskar, Milan, Nath, Aswathy G., Prakash, Devu, Srivastava, Shweta, Imo Singh, Wahengbam, Chandrasekharan, Malini, Oswal, Kunal et al. · 2026 · AJOG Global Reports
  37. Primary Screening by Human Papillomavirus Testing: Development, Implementation, and Perspectives
    Chris J.L.M. Meijer, Jack M. Cuzick, Wieke W. Kremer, Daniëlle A.M. Heideman, Guglielmo Ronco · 2019 · Elsevier eBooks
  38. What is the Retrospective Correlation between High- Grade Squamous Intraepithelial Lesion (HSIL) on Cytology and the Histological Diagnosis of Cervical Intraepithelial Neoplasia 2 (CIN2) or More in AML, Antwerp, Belgium?
    Nina Karia, Alison Van Loon, Ina H. Benoy, Johannes Bogers · 2020
  39. Papillomavirus humains : dépistage et prévention
    Sébastien Hantz · 2021 · Revue Francophone des Laboratoires
  40. A Technical Comparison of Human Papillomavirus Genotyping Assays from a Population-Based Cervical Cancer Screening in South Central Ethiopia
    Brhanu Teka, Muluken Gizaw, Ededia Firdawoke, Adamu Addissie, Tesfamichael Awoke, Carola Schreckenberger, Anna Sophie Skof, Sarah Thies, Adane Mihret, Eva Johanna Kantelhardt et al. · 2022 · Cancer Management and Research
  41. HPV test as a primary screening test in the prevention of cervical carcinoma in the Republic of Croatia
    Jasmina Vraneš · 2022 · Glasnik javnog zdravlja
  42. Clinical Validation of the Vitro HPV Screening Assay for Its Use in Primary Cervical Cancer Screening
    Beatríz Bellosillo, Raquel Ibáñez, Esther Roura, Laura Monfil, Laura Asensio-Puig, Isabel Álvarez, Mercè Muset, Yolanda Florencia, Sònia Paytubi, Álvaro de Andrés-Pablo et al. · 2024 · Cancers
  43. Prognostic value of HPV genotyping in cutaneous warts
    Nina Redzic · 2024
  44. Cost-effectiveness of human papillomavirus self-sampling in the Swedish cervical screening program
    Ellinor Östensson, Christer Borgfeldt, Kine Pedersen, Kristina Hellman, Stephen Sy, Jiayao Lei, Emily Annika Burger, Mark Clements · 2025 · medRxiv
  45. Clinical Validation of the Venus HPV Full‐Genotyping Assay for Cervical Cancer Screening in the VALGENT‐4 Framework
    Lan Xu, Chang Ma, Kate S. Cuschieri, Jesper Hansen Bonde, Marc Arbyn · 2025 · Journal of Medical Virology
  46. Reproducibility of HPV Testing With Two Versions of the Papilloplex High‐Risk HPV Assay
    Pui Yan Jenny Chung, Alice Baraquin, Killian Jacquot, Yuliya Tkachenka, Line Puget, Quentin Lepiller, Davy Vanden Broeck, Jean‐Luc Prétet, Marc Arbyn · 2025 · Journal of Medical Virology
  47. Multi-centre clinical validation of the NeuMoDx HPV assay for ASC-US / LSIL triage
    Taeyang Chin, Anja Oštrbenk, Nick Verhavert, Mario Poljak, Elizaveta Y. Padalko · 2025 · Diagnostic Microbiology and Infectious Disease
  48. Additional file 1 of VALCOR: a protocol for the validation of SARS-corona virus-2 assays
    Arbyn, Marc, Sharonjit Kaur Dhillon, Martinelli, Marianna, Cindy Simoens, Lize Cuypers, Jannes Bode, Van Ranst, Marc, Philippe Corbisier, Bonde, Jesper, Cocuzza, Clementina · 2022 · Figshare
  49. Head‐to‐head comparison of the MyGen e human papillomavirus–sexually transmitted infection assay versus the Cobas 4800 human papillomavirus test for detecting high‐grade cervical intraepithelial neoplasia
    Hang Zhou, Hua Zhang, Rong Pi, Yuan Yang, Tingyuan Li, S Chen, Yiran Chen, Yu Dai, He Zhu, Yuqian Zhao et al. · 2026 · International Journal of Gynecology & Obstetrics
  50. Negative Xpert HPV Test (Cepheid) With Late Amplification Signals: Is There a Clinical Significance? (the PaPCR Study)
    Valentin Lemoine, Romain Legros, Sylvain Rosec, Camille Salaun, Adissa Minoui-Tran, Léa Pilorgé, Sophie Vallet, Anne Le Gourrierec, Pierre Alemany, Pascale Marcorelles et al. · 2026 · Journal of Medical Virology
  51. Health Care Policy Implementation Trial of Primary Human Papillomavirus–Based Cervical Screening in Denmark
    Jesper Hansen Bonde, Jeppe Bennekou Schroll, Birgitte Tønnes Pedersen, Elsebeth Lynge, Marianne Waldstrøm, Petra Hall Viborg, Anna Poulsgaard Frandsen, Rikke H. Andersen, Susanne Nielsen, Doris Schledermann et al. · 2026 · International Journal of Cancer
  52. Secondary prevention; screening
    Nadereh Behtash, Narges Izadimood, Somayyeh Noei Teymoordash, Sara Ramhormozian · 2026 · Elsevier eBooks
  53. Comparative Evaluation of HPV PLUS ELITe MGB® and Allplex™ HPV HR Assays for High‐Risk Human Papillomavirus Genotyping in Cervical Samples
    Sarah Mafi, Julie Delpont, Amandine Bigot, Sébastien Hantz · 2026 · Journal of Medical Virology
  54. Eficacia y coste-efectividad de incluir el genotipado de VPH en el cribado de cáncer de cérvix
    Antonio Gutiérrez-Pizarraya, José María Maesa Márquez, Rocío Rodriguez López, Juan Antonio Blasco‐Amaro, Francisco Jódar Sánchez, Nuria García-Agua-Soler, Maria Luz González-Álvarez, Antonio José García-Ruiz · 2026
  55. Type-specific sensitivity versus detection breadth in HPV diagnostics: improved analytical detection of HPV16/18 by nested PCR
    Yago Tomaz Vieira da Silva, Larissa Alves Honorato Ferreira, Samara Fontes de Lima Gomes, Beatriz Helena Dantas Rodrigues de Albuquerque, Maryana Thalyta Ferreira Câmara de Oliveira, Alice Dantas Leite, José Veríssimo Fernandes, Ricardo Ney Cobucci, Daniel Carlos Ferreira Lanza · 2026 · Archives of Virology
  56. Clinical Validation of the Sansure Human Papillomavirus DNA Diagnostic Kit for Use in Primary Cervical Cancer Screening
    Sharonjit Kaur Dhillon, Ardashel Latsuzbaia, Davy Vanden Broeck, Jean‐Luc Prétet, Yuliya Tkachenka, Quentin Lepiller, Alice Baraquin, Killian Jacquot, Ana Rita Pereira, Nina Redzic et al. · 2026 · Journal of Medical Virology
  57. Genotype-specific agreement and accuracy of human papillomavirus DNA detection using AnyplexTM II HPV28 and XpertTM HPV among women with HIV in Lusaka, Zambia: a diagnostic accuracy analysis
    Nathalie Verónica Fernández Villalobos, Marionka Pohl, John Andoh, Allison Glass, Partha Sarathi Basu, Thamsanqa Madliwa, Mulindi Mwanahamuntu, Eliane Rohner, Nicola Low, Albert Manasyan et al. · 2026 · IJID Regions